Teva Announces Launch of New Generic Drug

The generic drug giant has 180 days of exclusivity for its generic version of Niaspan, a niacin-extended release tablet marketed by AbbVie.

comments Print
Teva Pharmaceuticals is launching a generic version of a drug with $1.1 billion in sales in the U.S. market, the generic drug giant announced Friday.